Akari Depreciation And Amortization vs Non Current Liabilities Total Analysis

AKTX Stock  USD 1.19  0.01  0.83%   
Akari Therapeutics financial indicator trend analysis is way more than just evaluating Akari Therapeutics PLC prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Akari Therapeutics PLC is a good investment. Please check the relationship between Akari Therapeutics Depreciation And Amortization and its Non Current Liabilities Total accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akari Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Depreciation And Amortization vs Non Current Liabilities Total

Depreciation And Amortization vs Non Current Liabilities Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Akari Therapeutics PLC Depreciation And Amortization account and Non Current Liabilities Total. At this time, the significance of the direction appears to have weak relationship.
The correlation between Akari Therapeutics' Depreciation And Amortization and Non Current Liabilities Total is 0.31. Overlapping area represents the amount of variation of Depreciation And Amortization that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Akari Therapeutics PLC, assuming nothing else is changed. The correlation between historical values of Akari Therapeutics' Depreciation And Amortization and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation And Amortization of Akari Therapeutics PLC are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Depreciation And Amortization i.e., Akari Therapeutics' Depreciation And Amortization and Non Current Liabilities Total go up and down completely randomly.

Correlation Coefficient

0.31
Relationship DirectionPositive 
Relationship StrengthVery Weak

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Non Current Liabilities Total

Most indicators from Akari Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Akari Therapeutics PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akari Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Selling General Administrative is likely to drop to about 7.6 M in 2025. Tax Provision is likely to drop to about (3 M) in 2025
 2021 2022 2024 2025 (projected)
Net Interest Income10.6K45.9K41.3K70.5K
Interest Income10.6K45.9K41.3K39.3K

Akari Therapeutics fundamental ratios Correlations

0.710.650.650.7-0.69-0.180.430.680.710.830.61-0.350.210.630.70.62-0.460.90.04-0.46-0.55-0.550.790.280.59
0.710.850.880.99-0.990.090.730.991.00.40.6-0.230.080.881.00.59-0.410.86-0.15-0.41-0.45-0.440.830.080.93
0.650.850.990.78-0.86-0.220.570.860.850.340.49-0.220.310.990.850.5-0.420.680.09-0.42-0.53-0.510.80.130.79
0.650.880.990.81-0.89-0.20.690.890.880.310.47-0.170.31.00.880.48-0.390.690.09-0.39-0.52-0.50.830.130.84
0.70.990.780.81-0.970.160.720.970.990.420.6-0.230.010.810.990.59-0.410.88-0.19-0.41-0.42-0.40.80.090.92
-0.69-0.99-0.86-0.89-0.97-0.1-0.73-1.0-0.99-0.34-0.560.25-0.06-0.89-0.99-0.560.39-0.850.150.390.430.41-0.81-0.02-0.91
-0.180.09-0.22-0.20.16-0.1-0.080.110.12-0.270.07-0.51-0.94-0.180.090.050.590.15-0.860.590.680.69-0.32-0.130.12
0.430.730.570.690.72-0.73-0.080.730.710.120.240.130.210.670.730.24-0.20.50.14-0.2-0.37-0.370.70.110.75
0.680.990.860.890.97-1.00.110.730.990.330.56-0.250.050.890.990.56-0.380.85-0.16-0.38-0.42-0.40.80.00.91
0.711.00.850.880.99-0.990.120.710.990.380.57-0.270.040.881.00.57-0.380.87-0.17-0.38-0.42-0.40.80.080.93
0.830.40.340.310.42-0.34-0.270.120.330.380.66-0.130.30.30.40.66-0.440.710.03-0.44-0.53-0.530.650.180.22
0.610.60.490.470.6-0.560.070.240.560.570.66-0.35-0.020.50.61.0-0.320.74-0.45-0.32-0.4-0.390.72-0.080.37
-0.35-0.23-0.22-0.17-0.230.25-0.510.13-0.25-0.27-0.13-0.350.6-0.19-0.23-0.35-0.23-0.410.57-0.23-0.23-0.22-0.01-0.17-0.23
0.210.080.310.30.01-0.06-0.940.210.050.040.3-0.020.60.280.080.0-0.64-0.040.82-0.64-0.72-0.750.40.040.02
0.630.880.991.00.81-0.89-0.180.670.890.880.30.5-0.190.280.880.5-0.380.690.06-0.38-0.5-0.480.830.130.83
0.71.00.850.880.99-0.990.090.730.991.00.40.6-0.230.080.880.59-0.410.86-0.15-0.41-0.45-0.430.830.080.93
0.620.590.50.480.59-0.560.050.240.560.570.661.0-0.350.00.50.59-0.340.73-0.42-0.34-0.42-0.40.73-0.060.37
-0.46-0.41-0.42-0.39-0.410.390.59-0.2-0.38-0.38-0.44-0.32-0.23-0.64-0.38-0.41-0.34-0.35-0.531.00.830.83-0.59-0.13-0.26
0.90.860.680.690.88-0.850.150.50.850.870.710.74-0.41-0.040.690.860.73-0.35-0.29-0.35-0.44-0.420.790.080.72
0.04-0.150.090.09-0.190.15-0.860.14-0.16-0.170.03-0.450.570.820.06-0.15-0.42-0.53-0.29-0.53-0.51-0.530.120.32-0.06
-0.46-0.41-0.42-0.39-0.410.390.59-0.2-0.38-0.38-0.44-0.32-0.23-0.64-0.38-0.41-0.341.0-0.35-0.530.830.83-0.59-0.13-0.26
-0.55-0.45-0.53-0.52-0.420.430.68-0.37-0.42-0.42-0.53-0.4-0.23-0.72-0.5-0.45-0.420.83-0.44-0.510.830.99-0.71-0.1-0.33
-0.55-0.44-0.51-0.5-0.40.410.69-0.37-0.4-0.4-0.53-0.39-0.22-0.75-0.48-0.43-0.40.83-0.42-0.530.830.99-0.69-0.14-0.31
0.790.830.80.830.8-0.81-0.320.70.80.80.650.72-0.010.40.830.830.73-0.590.790.12-0.59-0.71-0.690.150.69
0.280.080.130.130.09-0.02-0.130.110.00.080.18-0.08-0.170.040.130.08-0.06-0.130.080.32-0.13-0.1-0.140.150.24
0.590.930.790.840.92-0.910.120.750.910.930.220.37-0.230.020.830.930.37-0.260.72-0.06-0.26-0.33-0.310.690.24
Click cells to compare fundamentals

Akari Therapeutics Account Relationship Matchups

Akari Therapeutics fundamental ratios Accounts

202020212022202320242025 (projected)
Common Stock Shares Outstanding1.6M2.1M3.1M4.9M5.6M4.7M
Total Assets17.6M11.6M13.8M4.4M5.0M4.8M
Other Current Liab1.8M4.3M11.1M2.9M3.3M5.7M
Total Current Liabilities5.2M6.1M12.0M4.6M5.3M7.9M
Total Stockholder Equity12.4M5.6M1.8M(229K)(206.1K)(195.8K)
Net Debt(14.1M)(9.4M)(13.2M)(3.8M)(4.4M)(4.6M)
Retained Earnings(156.6M)(199.7M)(217.5M)(227.5M)(204.7M)(194.5M)
Accounts Payable3.4M1.8M947K1.7M1.9M2.1M
Cash14.1M9.4M13.2M3.8M3.5M3.3M
Cash And Short Term Investments14.1M9.4M13.2M3.8M3.5M3.3M
Liabilities And Stockholders Equity17.6M11.6M13.8M4.4M5.0M4.8M
Non Current Liabilities Total1.0M3.4M4.3M946.7K1.1M1.1M
Other Stockholder Equity191.9M205.3M219.3M174.8M201.0M117.1M
Total Liab5.2M6.1M12.0M4.6M5.3M8.1M
Total Current Assets17.6M11.6M13.8M4.3M5.0M4.7M
Accumulated Other Comprehensive Income(10.9M)(541.0K)(770.8K)51.2M58.8M61.8M
Common Stock385K476.0K744.5K1.3M1.5M1.4M
Non Current Assets Total27K22.9K16.9K14K12.6K12.0K
Property Plant And Equipment Gross20.4K5.0K172K164.9K197.8K207.7K
Intangible Assets27K22.9K16.9K14K16.1K28.1K
Net Tangible Assets3.1M(1.8M)9.4M5.5M5.0M4.7M
Other Current Assets521.9K2.3M564.8K496K570.4K954.4K
Net Invested Capital(1.8M)9.4M5.6M1.8M1.6M1.5M
Net Working Capital(1.8M)9.4M5.5M1.8M1.6M1.5M
Capital Stock32.0M384.7K476.0K744.5K670.0K636.5K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Akari Stock Analysis

When running Akari Therapeutics' price analysis, check to measure Akari Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akari Therapeutics is operating at the current time. Most of Akari Therapeutics' value examination focuses on studying past and present price action to predict the probability of Akari Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akari Therapeutics' price. Additionally, you may evaluate how the addition of Akari Therapeutics to your portfolios can decrease your overall portfolio volatility.